Cargando…
A rare presentation of Sintilimab-induced swelling along the vessels: Case report
Immune-related adverse events are occasionally reported in Sintilimab treatment. This study reports a forward and reverse swelling case along the vein after infusion of Sintilimab. At present, swelling along the vascular direction during peripheral infusion are limitedly reported at home and abroad,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219706/ https://www.ncbi.nlm.nih.gov/pubmed/37233405 http://dx.doi.org/10.1097/MD.0000000000033859 |
_version_ | 1785049070781333504 |
---|---|
author | Liu, Liqiong Yu, Yang Xia, Juan Ning, Yanting |
author_facet | Liu, Liqiong Yu, Yang Xia, Juan Ning, Yanting |
author_sort | Liu, Liqiong |
collection | PubMed |
description | Immune-related adverse events are occasionally reported in Sintilimab treatment. This study reports a forward and reverse swelling case along the vein after infusion of Sintilimab. At present, swelling along the vascular direction during peripheral infusion are limitedly reported at home and abroad, especially when choosing a vein with thick, elastic, and good blood return. PATIENT CONCERNS: A 56-year-old male who suffered from esophageal cancer and liver cancer and received albumin-bound paclitaxel and nedaplatin chemotherapy in combination with Sintilimab immunotherapy appeared swelling along the vessel after infusion of Sintilimab. The patient was punctured 3 times. DIAGNOSES: Sintilimab-induced vascular edema may be a side effect resulted from a combination of variables such as relatively poor vascular function of the patient, chemical extravasation, allergic skin reactions, venous valves, vascular intima, and diameter stenosis. Sintilimab rarely causes vascular edema only when drug allergic reaction is the underlying factor. As only a few cases of vascular edema caused by Sintilimab have been reported, causes to such a drug-induced vascular edema remained unclear. INTERVENTIONS: The swelling was controlled by an intravenous specialist nurse according to delayed extravasation treatment and the doctor anti-allergy treatment, but the uncertainty of repeated puncture and symptom diagnosis caused pain and anxiety to the patient and his family. OUTCOMES: The symptom of swelling was gradually relieved after the anti-allergic treatment. The patient completed the following drug infusion without discomfort after the third puncture. When the patient was discharged the next day, swelling in his both hands disappeared, and the patient had no anxiety or discomfort. LESSONS: The side effects of immunotherapy may accumulate over time. Early identification and appropriate nursing management are the keys to minimizing patients’ pain and anxiety. To effectively treat symptoms, nurses could benefit from quickly identifying the source of swelling. |
format | Online Article Text |
id | pubmed-10219706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-102197062023-05-27 A rare presentation of Sintilimab-induced swelling along the vessels: Case report Liu, Liqiong Yu, Yang Xia, Juan Ning, Yanting Medicine (Baltimore) 5700 Immune-related adverse events are occasionally reported in Sintilimab treatment. This study reports a forward and reverse swelling case along the vein after infusion of Sintilimab. At present, swelling along the vascular direction during peripheral infusion are limitedly reported at home and abroad, especially when choosing a vein with thick, elastic, and good blood return. PATIENT CONCERNS: A 56-year-old male who suffered from esophageal cancer and liver cancer and received albumin-bound paclitaxel and nedaplatin chemotherapy in combination with Sintilimab immunotherapy appeared swelling along the vessel after infusion of Sintilimab. The patient was punctured 3 times. DIAGNOSES: Sintilimab-induced vascular edema may be a side effect resulted from a combination of variables such as relatively poor vascular function of the patient, chemical extravasation, allergic skin reactions, venous valves, vascular intima, and diameter stenosis. Sintilimab rarely causes vascular edema only when drug allergic reaction is the underlying factor. As only a few cases of vascular edema caused by Sintilimab have been reported, causes to such a drug-induced vascular edema remained unclear. INTERVENTIONS: The swelling was controlled by an intravenous specialist nurse according to delayed extravasation treatment and the doctor anti-allergy treatment, but the uncertainty of repeated puncture and symptom diagnosis caused pain and anxiety to the patient and his family. OUTCOMES: The symptom of swelling was gradually relieved after the anti-allergic treatment. The patient completed the following drug infusion without discomfort after the third puncture. When the patient was discharged the next day, swelling in his both hands disappeared, and the patient had no anxiety or discomfort. LESSONS: The side effects of immunotherapy may accumulate over time. Early identification and appropriate nursing management are the keys to minimizing patients’ pain and anxiety. To effectively treat symptoms, nurses could benefit from quickly identifying the source of swelling. Lippincott Williams & Wilkins 2023-05-26 /pmc/articles/PMC10219706/ /pubmed/37233405 http://dx.doi.org/10.1097/MD.0000000000033859 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | 5700 Liu, Liqiong Yu, Yang Xia, Juan Ning, Yanting A rare presentation of Sintilimab-induced swelling along the vessels: Case report |
title | A rare presentation of Sintilimab-induced swelling along the vessels: Case report |
title_full | A rare presentation of Sintilimab-induced swelling along the vessels: Case report |
title_fullStr | A rare presentation of Sintilimab-induced swelling along the vessels: Case report |
title_full_unstemmed | A rare presentation of Sintilimab-induced swelling along the vessels: Case report |
title_short | A rare presentation of Sintilimab-induced swelling along the vessels: Case report |
title_sort | rare presentation of sintilimab-induced swelling along the vessels: case report |
topic | 5700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219706/ https://www.ncbi.nlm.nih.gov/pubmed/37233405 http://dx.doi.org/10.1097/MD.0000000000033859 |
work_keys_str_mv | AT liuliqiong ararepresentationofsintilimabinducedswellingalongthevesselscasereport AT yuyang ararepresentationofsintilimabinducedswellingalongthevesselscasereport AT xiajuan ararepresentationofsintilimabinducedswellingalongthevesselscasereport AT ningyanting ararepresentationofsintilimabinducedswellingalongthevesselscasereport AT liuliqiong rarepresentationofsintilimabinducedswellingalongthevesselscasereport AT yuyang rarepresentationofsintilimabinducedswellingalongthevesselscasereport AT xiajuan rarepresentationofsintilimabinducedswellingalongthevesselscasereport AT ningyanting rarepresentationofsintilimabinducedswellingalongthevesselscasereport |